VITA Study

Clinical Research Study for Immune-Mediated Thrombotic Thrombocytopenic Purpura

The VITA Study is looking for adults ages 18 or older who are diagnosed with immune-mediated thrombotic thrombocytopenic purpura (iTTP) and experiencing an acute episode. The purpose of the study is to evaluate the safety and effectiveness of an investigational study drug, called TAK-755, in combination with little to no plasma exchange (PEX). The study drug is available at the institutions listed below. To learn more, please contact a participating site or click on the Clinicaltrials.gov link below.

https://clinicaltrials.gov/ct2/show/NCT05714969

University of Minnesota Med CAR
Minneapolis, Minnesota, United States, 55455
Contact: Site Contact 612-626-3757

Duke University Medical Center
Durham, North Carolina, United States, 27710
Contact: Site Contact 919-684-5350

Leo Jenkins Cancer Center/ECU School of Medicine
Greenville, North Carolina, United States 27834
Contact: Site Contact 252-744-3556

Ohio State University
Columbus, Ohio, United States 43210
Contact: Site Contact 614-293-2887